Ellerston Capital buys stake in Morphic
Ellerston Capital has announced it has acquired a controlling interest in Morphic Ethical Equities Fund’s (MEC) manager, Morphic Asset Management, which is a specialist investment manager in alternative strategies such as separately managed accounts (SMAs).
Under the terms of the deal, Morphic would become a subsidiary of Ellerston, and Morphic’s founders, Jack Lowenstein and Chad Slater, would continue to run the funds while gaining access to Ellerston’s wider analyst pool and infrastructure.
“We believe that under the wing of Ellerston, we gain access to Ellerston’s experienced investment team and we substantially improve our reach to investors whose aim is to build wealth by following the principles of socially responsible investing,” Lowenstein commented.
According to Morphic Ethical Fund’s chair’s JoAnna Fisher, the transaction was expected to be a positive development for the fund and would support the fund’s marketing efforts.
AUTHOR
Oksana Patron
Recommended for you
The merger with L1 Capital will “inject new life” into Platinum, Morningstar believes, but is unlikely to boost Platinum’s declining funds under management.
More than half of the top 20 most popular shares bought by advised investors during the first half of 2025 were ETFs, according to AUSIEX data.
At least two-thirds of ETF flows are understood to be driven by intermediaries, according to Global X, as net flows into Australian ETFs spike 97 per cent in the first half of 2025.
Inflows for the first half of 2025 for GQG Partners stand at US$8 billion, but the firm has flagged fund underperformance could be a headwind for future flows.
